Is Primary Biliary Cirrhosis an Autoimmune Disease?

References

• Rose N R, Bona C. Defining criteria for autoimmune diseases (Witebsky's postulates revisited). Immunol Today 1993; 14: 426–30
   PubMedGoogle Scholar
• Baum H, Berg P. The complex nature of mitochondria1 antibodies and their relation to primary biliary cirrhosis. Sem Liver Dis 1981; 1: 309–21
   PubMedGoogle Scholar
• Berg P A, Baum H. Serology of primary biliary cirrhosis. Springer Sem Immunopath 1980; 3: 355–73
   PubMedGoogle Scholar
• Van de Water J, Gershwin M E, Leung P, Ansari A, Coppel R L. The autoepitope of the 74 kD mitochondrial autoantigen of primary biliary cirrhosis corresponds to the functional site of dihvdrofipoamide acetyltransferase. J Exp Med 1988; 167: 1791–9
   PubMed Web of Science ®Google Scholar
• Fussey S, Guest J R, James O FW, Bassendine M, Yeaman S J. Identification and analysis of the major M2 autoantigens in primary biliary cirrhosis. Proc Natl Acad Sci USA 1988; 85: 8654–8
   PubMed Web of Science ®Google Scholar
• Fregeau D R, Roche T E, Davis P A, Coppel R, Gershwin M E. Inhibition of pyruvate dehydrogenase complex activity by autoantibodies specific for EIα, a non-lipoic acid containing mitochondrial enzyme. J Immunol 1990; 144: 1671–6
   PubMed Web of Science ®Google Scholar
• Bassendine M F, Yeaman S J. Serological markers of primary biliary cirrhosis: diagnosis, prognosis and subsets. editorial comment Hepatology 1992; 15: 545–8
   PubMedGoogle Scholar
• Mendel-Hartvig I, Björkland A, Nelson B D, Norberg R, Ytterström U, Tötterman T H. Primary biliary cirrhosis: indication for a single mitochondrial antigenic epitope detected by patient autoantibodies and a novel monoclonal antibody. Scand J Immunol 1988; 28: 403–10
   PubMedGoogle Scholar
• Krams S, Van de Water J, Coppel R, Esquivel C, Roberts J, Ansari A, et al. Analysis of hepatic T lymphocyte and immunoglobulin deposits in patients with primary biliary cirrhosis. Hepatology 1990; 12: 306–13
   PubMed Web of Science ®Google Scholar
• Björkland A, Lööf L, Mendel-Hartvig I, Tötterman T H. Primary biliary cirrhosis: high proportions of B cells in blood and liver tissue producing anti-mitochondrial antibodies of several Ig classes. J Immunol, in press
   Google Scholar
• Czerkinsky C, Nilsson L-Å, Nygren H, Ouchterlony ö, Tarkowski A. A solid-phase enzyme-linked immunospot (ELI-SPOT) assay for enumeration of specific antibody-secreting cells. J Immunol Meth 1983; 65: 109–16
   PubMed Web of Science ®Google Scholar
• Stanley C, Perham R. Purification of 2-oxo acid dehydrogenase multienzvme complexes from heart by a new method. Biochem J 1980; 191: 147–56
   PubMed Web of Science ®Google Scholar
• Van de Water J, Ansari A, Surh C, Coppel R, Roche T, Bonkovsky H, et al. Evidence for the targeting by 2-oxo-dehvdrogenase enzymes in the T cell response of primary biliary cirrhosis. J Immunol 1991; 146: 89–94
   PubMed Web of Science ®Google Scholar
• Löhr H, Fleischer B, Gerken G, Yeaman S G, Meyer zum Büschenfelde K H, Manns M. Autoreactive liver-infiltrating T cells in primary biliary cirrhosis recognize inner mitochondrial epitopes and the pyruvate dehydrogenase complex. J Hepatol 1993; 18: 322–7
   PubMed Web of Science ®Google Scholar
• Uibo R, MacKay R, Rowley M, Humphries P, Armstrong J, McNeilage J. Inhibition of enzyme function by human autoantibodies to an autoantigen pyruvate dehydrogenase E2: different epitope for spontaneous human and induced rabbit autoantibodies. Clin Exp Immunol 1989; 80: 19–24
   Google Scholar
• Krams S, Surh C, Coppel R, Ansari A, Ruebner B, Gershwin E. Immunization of experimental animals with dihydrolipoamide acetyltransferase, as a purified recombinant polypeptide generates mitochondrial antibodies but not primary biliary cirrhosis. Hepatology 1989; 9: 411–6
   PubMedGoogle Scholar
• Krams S M, Dorshkind K, Gershwin M E. Generation of biliary lesions after transfer of human lymphocytes into severe combined immunodeficient(SCID) mice. J Exp Med 1989; 170: 1919–30
   PubMed Web of Science ®Google Scholar
• MacSween R, Burt A. The cellular pathology of primary biliary cirrhosis. Mol Aspects Med 1985; 3: 269–91
   Google Scholar
• Ballardini G, Mirakian R, Bianchi F, Pisi E, Doniach D, Bottazzo G. Aberrant expression of HLA-DR antigens on bile duct epithelium in primary biliary cirrhosis: relevance to pathogenesis. Lancet 1984; ii: 1009–10
   Google Scholar
• Si L, Whiteside T, Schade R, Starzl T, van Thiel D. T-lymphocyte subsets in liver tissues of patients with primary biliary-cirrhosis (PBC) patients with primary sclerosing cholangitis (PSC) and normal controls. J Clin Immunol 1984; 4: 262–72
   PubMed Web of Science ®Google Scholar
• Shimizu M, Yuh K, Aoyama S, Ichihara I, Watanabe H, Shijo H, et al. Immunohistochemical characterization of inflammatory infiltrates at the site of bile duct injury in primary biliary cirrhosis. Liver 1986; 6: 1–6
   PubMedGoogle Scholar
• Björkland A, Festin R, Nyberg A, Lööf L, Mendel-Hartvig I, Totterman T. Blood and liver-infiltrating lymphocytes in primary biliary cirrhosis: increase in activated T and NK cells and decrease in suppressor inducer T cells detected by 2-color FACS analysis. Hepatology 1991; 13: 1106–11
   PubMed Web of Science ®Google Scholar
• Duby A D, Sinclair A K, Osborne-Lawrence S L, Zeldes L, Kan L, Fox D A. Clonal heterogeneity of synovial fluid T lymphocytes from patients with rheumatoid arthritis. Proc Natl Acad Sci 1989; 86: 6206–10
   PubMed Web of Science ®Google Scholar
• Culp K, Fleming R, Duffy J, Baldus W, Dickson R. Autoimmune associations in primary biliary cirrhosis. Mayo Clin Proc 1982; 57: 365–70
   PubMed Web of Science ®Google Scholar
• Modena V, Marengo C, Amoroso A, Rosina F, Constantini P, Bellando P, et al. Primary biliary cirrhosis and rheumatic diseases: a clinical immunological and immunogenetical study. Clin Exp Rheum 1986; 4: 129–34
   PubMedGoogle Scholar
• Bassendine M, Dewar P, James F. HLA-DR antigens in primary biliary cirrhosis: lack of association. Gut 1985; 26: 625–8
   PubMedGoogle Scholar
• Gores G, Moore S B, Fisher L D, Powell F C, Dickson E R. Primary biliary cirrhosis: association with class II major histocompatibility complex antigen. Hepatology 1987; 7: 889–92
   PubMed Web of Science ®Google Scholar
• Gregory W L, Mehal W Z, Dunn A N, Cavanagh G, Chapman R, Flemming K A. PBC weakly associated with HLA class II genotype DR8. QJM 1993; 86: 393–9
   PubMedGoogle Scholar
• Underhill J, Donaldsson P, Bray G, Doherty D, Portmann B, Williams R. Susceptibility to primary biliary cirrhosis is associated with the HLA-DR8-DQB 1*0402 haplotype. Hepatology 1992; 16: 1404–8
   PubMed Web of Science ®Google Scholar
• Mehal W Z, Gregory W, Cross S, Flemming K A, Campbell R D, James O FW, et al. Localization of the immunogenetic susceptibility in primary biliary cirrhosis. Gastroenterology 1993; 104: A953
   Google Scholar
• Christensen E, Neuberger J, Crowe J, Altman D G, Popper H, Portmann B, et al. Beneficial effect of azathioprine and prediction of prognosis in primary biliary cirrhosis. Gastroenterology 1985; 89: 1084–91
   PubMed Web of Science ®Google Scholar
• Mitchison H C, Bassendine M F, Malcolm A J, Watson A J, Record C O, James O F. A pilot, double-blind, controlled 1-year trial of prednisolone treatment in primary biliary cirrhosis: hepatic improvement but greater bone loss. Hepatology 1989; 10: 420–9
   PubMed Web of Science ®Google Scholar
• Karlsson-Parra A, Totterman T H, Nyberg A, Mendel-Hartvig I, Lööf L, Forsum U. Immunological effects of ciclosporin in primary biliary cirrhosis: suppression of activated T cells and autoantibody levels. Int Arc Allerg Appl Immun 1987; 83: 256–64
   PubMedGoogle Scholar
• Dickson R, Fleming T, Wiesner R, Baldus W, Fleming R, Ludwig J, et al. Trial of penicillamine in advanced primary biliary cirrhosis. N Engl J Med 1985; 312: 1011–5
   PubMed Web of Science ®Google Scholar
• Lindenborn-Fotinos J, Baum H, Berg P. Mitochondrial antibodies in primary biliary cirrhosis: species and non-species-specific determinants of M2-antigen. Hepatology 1985; 5: 763–9
   PubMed Web of Science ®Google Scholar
• Lennon V A, Lambert E H. Myasthenia gravis induced by monoclonal antibodies to acetylcholine receptors. Nature 1980; 285: 238–40
   PubMed Web of Science ®Google Scholar
• Chan E KL, Tan E M. Human autoantibody reactive epitopes of SS-B/La are highly conserved in comparison with epitopes recognized by murine monoclonal antibodies. J Exp Med 1987; 166: 1627–40
   PubMed Web of Science ®Google Scholar
• Huff J P, Ross G, Peebles C L, Houghten R, Sullivan K F, Tan E M. Insights into native epitopes of proliferating cell nuclear antigen using recombinant DNA protein products. J Exp Med 1990; 172: 419–23
   PubMed Web of Science ®Google Scholar
• Portanova J P, Cheronis J C, Blodgett J K, Kotzin B L. Histone autoantigens in murine lupus. Definition of a major epitope within an accessible region of chromatin. J Immunol 1990; 144: 4633–8
   PubMed Web of Science ®Google Scholar
• Harrison L C, Campbell I L, Allison J, Allison J, Miller J F. MHC molecules and beta-cell destruction. Diabetes 1989; 38: 815–8
   PubMedGoogle Scholar
• Liu Y, Linsley P S. Costimulation of T-cell growth. Curr Opin Immunol 1992; 4: 265–70
   PubMedGoogle Scholar
• Joplin R, Lindsay J G, Hubscher S G, Johnson G D, Shaw J C, Strain A J, et al. Distribution of dihydrolipoamide acetyl-transferase (E2) in the liver and portal lymph nodes of patients with primary biliary cirrhosis: an immunohistochemical study. Hepatology 1990; 14: 442–7
   Google Scholar
• Joplin R, Lindsay J G, Johnsson G D, Strain A, Neuberger J. Membrane dihydrolipoamide acetyltransferase (E2) on human biliary epithelial cells in primary biliary cirrhosis. Lancet 1992; 339: 93–4
   PubMedGoogle Scholar
• Van de Water J, Turchany, Leung P SC, Lake J, Munoz S, Surh C D, et al. Molecular mimicry in primary biliary cirrhosis: evidence for biliary epithelial expression of a molecule cross-reactive with pyruvate dehydrogenase complex-E2. J Clin Invest 1993; 91: 2653–64
   PubMed Web of Science ®Google Scholar
• Mackay I R, Gershwin M E. Primary biliary cirrhosis: considerations on pathogenesis based on identification of the M2 autoantigens. Springer Semin Immunopathol 1990; 12: 101–19
   PubMedGoogle Scholar
• Fusconi M, Baum H, Caselli A, Cassani F, Ballardini G, Lenzi M, et al. Demonstration of peptide-specific and cross-reactive epitopes in proteins reacting with antimitochondrial antibodies of primary biliary cirrhosis. J Hepatol 1992; 15: 162–9
   PubMedGoogle Scholar
• Fussey S PM, Lindsay J G, Fuller C, Perham R N, Dale S FW, et al. Autoantibodies in primary biliary cirrhosis: analysis of reactivity against eukaryotic and prokaryotic 2-oxo acid dehydrogenase complexes. Hepatology 1990; 13: 467–74
   Google Scholar
• Klein R, Berg P A. Demonstration of naturally occurring mitochondrial antibodies (NOMA) by western blotting in families of patients with primary biliary cirrhosis. Hepatology 1988; 8: 1419–26
   Google Scholar
• Hopf U, Stemerowicz R, Rodloff A, Galanos C, Moller B, Lobeck H, et al. Relation between Escherichia coli R(rough)-forms in gut, lipid A in liver and primary biliary cirrhosis. Lancet 1989; ii: 1419–22
   Google Scholar
• Stemerowicz R, Hopf U, Moller B, Wittenbring C, Rodloff A, Reinhardt R, et al. Are antimitochondrial antibodies in primary biliary cirrhosis induced by rough mutants of Enterbacteriaceae. Lancet 1988; ii: 1166–70
   Google Scholar